Natus Medical’s Continued Commitment to Growth: Acquires NeuroCom International

In a move that underscores the Natus Medical’s continued commitment to growth, the company has acquired privately held NeuroCom International for $18 million.

NeuroCom develops diagnostics for chronic dizziness, balance, and mobility disorders. The company has developed the EquiTest which uses Computerized Dynamic Posturography to assess and monitor of balance disorders. NeuroCom reported revenue of $11.3 million in the trailing twelve months.

The acquisition adds to Natus’ growth opportunities by broadening its product offerings in the neurology space. The balance and mobility assessment market is potentially underdeveloped; Natus believes NeuroCom products could become the standard of care.

Natus will update its revenue and earnings guidance when it releases financial results for its third quarter ended September 30, 2008. Excluding any unforeseen events, the acquisition will be immediately accretive to earnings, excluding associated one-time charges.

Previously: Natus Further Consolidates U.S. Newborn Hearing Loss Screening Market with SonaMed Acquisition

Acquisition of Xltek to Strengthen Natus’ Neurology Division

The comments are closed.